These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16289503)

  • 1. TP53 codon 72 polymorphism and risk of conjunctival squamous cell carcinoma in Uganda.
    Tornesello ML; Waddell KM; Duraturo ML; Biryahwaho B; Downing R; Lucas SB; Giani U; Buonaguro L; Buonaguro FM
    Cancer Detect Prev; 2005; 29(6):501-8. PubMed ID: 16289503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of polymorphism in codon 72 of TP53 gene to laryngeal cancer in Polish patients.
    Zemleduch T; Lianeri M; Rydzanicz M; Gajecka M; Szyfter K; Jagodziński PP
    Oral Oncol; 2009 Aug; 45(8):683-6. PubMed ID: 19091625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.
    Langerød A; Bukholm IR; Bregård A; Lønning PE; Andersen TI; Rognum TO; Meling GI; Lothe RA; Børresen-Dale AL
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1684-8. PubMed ID: 12496062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of TP53 codon 72 polymorphism in HPV-positive and HPV-negative penile carcinoma.
    Tornesello ML; Duraturo ML; Guida V; Losito S; Botti G; Pilotti S; Stefanon B; De Palo G; Buonaguro L; Buonaguro FM
    Cancer Lett; 2008 Sep; 269(1):159-64. PubMed ID: 18513854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 mutations in squamous-cell carcinomas of the conjunctiva: evidence for UV-induced mutagenesis.
    Ateenyi-Agaba C; Dai M; Le Calvez F; Katongole-Mbidde E; Smet A; Tommasino M; Franceschi S; Hainaut P; Weiderpass E
    Mutagenesis; 2004 Sep; 19(5):399-401. PubMed ID: 15388813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 codon 72 polymorphism and risk of cervical carcinoma in Serbian women.
    Malisic E; Jankovic R; Brotto K; Radulovic S
    Arch Gynecol Obstet; 2013 Sep; 288(3):621-5. PubMed ID: 23483183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.
    Cortezzi SS; Provazzi PJ; Sobrinho JS; Mann-Prado JC; Reis PM; de Freitas SE; Filho JF; Fukuyama EE; Cordeiro JA; Cury PM; Maniglia JV; Villa LL; Tajara EH; Rahal P
    Cancer Genet Cytogenet; 2004 Apr; 150(1):44-9. PubMed ID: 15041222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
    Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
    Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi.
    Waddell KM; Lewallen S; Lucas SB; Atenyi-Agaba C; Herrington CS; Liomba G
    Br J Ophthalmol; 1996 Jun; 80(6):503-8. PubMed ID: 8759259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis.
    Kuroda Y; Nakao H; Ikemura K; Katoh T
    Oral Oncol; 2007 Nov; 43(10):1043-8. PubMed ID: 17306604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TP53 codon 72 polymorphism in oral squamous cell carcinoma.
    Drummond SN; De Marco L; Pordeus Ide A; Barbosa AA; Gomez RS
    Anticancer Res; 2002; 22(6A):3379-81. PubMed ID: 12530090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
    Hadhri-Guiga B; Toumi N; Khabir A; Sellami-Boudawara T; Ghorbel A; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R
    Cancer Genet Cytogenet; 2007 Oct; 178(2):89-93. PubMed ID: 17954263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
    Damin AP; Frazzon AP; Damin DC; Roehe A; Hermes V; Zettler C; Alexandre CO
    Cancer Detect Prev; 2006; 30(6):523-9. PubMed ID: 17113725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
    Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
    Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort.
    Pantelis A; Pantelis D; Ruemmele P; Hartmann A; Hofstaedter F; Buettner R; Bootz F; Stoehr R
    Oncol Rep; 2007 May; 17(5):1243-8. PubMed ID: 17390072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 codon 72 polymorphism and risk for cervical cancer in Portugal.
    Santos AM; Sousa H; Catarino R; Pinto D; Pereira D; Vasconcelos A; Matos A; Lopes C; Medeiros R
    Cancer Genet Cytogenet; 2005 Jun; 159(2):143-7. PubMed ID: 15899386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
    To-Figueras J; Gene M; Gomez-Catalan J; Galan C; Firvida J; Fuentes M; Rodamilans M; Huguet E; Estape J; Corbella J
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):337-42. PubMed ID: 9162298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 Codon 72 polymorphism and the risk of esophageal squamous cell carcinoma.
    Yang W; Zhang Y; Tian X; Ning T; Ke Y
    Mol Carcinog; 2008 Feb; 47(2):100-4. PubMed ID: 17918207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
    Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
    Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53 codon 72 polymorphism in squamous cell carcinoma of the head and neck region.
    Brant O; Hoffmann M; Kanappilly A; Görögh T; Gottschlich S
    Anticancer Res; 2007; 27(5A):3301-5. PubMed ID: 17970074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.